Polymyositis (PM), an autoimmune inflammatory myopathy, is frequently associated with autoantibodies. One subgroup of PM patients, marked by certain disease--specific anti-cytoplasmic autoantibodies (ACA), has a high frequency of interstitial lung disease, arthritis, and possibly other features. These ACA include anti-Jo-1, directed at histidyl-tRNA synthetase, antibodies to other amino-acyl-tRNA synthetases, and antibodies to other factors involved in translation and protein synthesis. The reason for the association of this clinical subgroup with antibodies to translation-related proteins than antibodies to nuclear proteins because they are mRNA viruses that interact with the translational apparatus. In this project we will investigate aspects of these antibodies. First, we will analyze certain key antigens in the group. Antibodies labeled KJ, CJ, and JP react with translation-related antigens, but do not precipitate tRNA as the anti-synthetases do. We will study the biochemical and molecular structure and cellular role of the antigens, and clone sequence the genes for the antigens. This could establish their relationship to translation and determine whether interaction, homology, or complementarity with known viral structures may occur. Second, we will study the question of the possible original immunogenic form of the antigen by analyzing the newly identified antibody reacting with the multi-enzyme synthetase complex. Anti-OJ reacts with multiple synthetase complex components, and immunoprecipitates many synthetases, but fewer than expected forms of tRNA. The antigenic components and the significance of the limited tRNA will be determined. Third, we will determine whether genetic features of the T- cell receptor can be identified that are associated with the production of this group of antibodies, or with the commonest of these antibodies, anti- Jo-1. These studies may provide insight into the reasons these antigens became immunogenic, and the reasons this group of antibodies is associated with this syndrome.

Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
James, J A; McClain, M T; Koelsch, G et al. (1999) Side-chain specificities and molecular modelling of peptide determinants for two anti-Sm B/B' autoantibodies. J Autoimmun 12:43-9
Huang, S C; Scofield, R H; Kurien, B T et al. (1997) Human anti-Ro autoantibodies bind multiple conformational epitopes of 60-kD Ro autoantigen. J Clin Immunol 17:212-9
Ge, Q; Wu, Y; James, J A et al. (1996) Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen. Arthritis Rheum 39:1588-95
Tsuzaka, K; Leu, A K; Frank, M B et al. (1996) Lupus autoantibodies to double-stranded DNA cross-react with ribosomal protein S1. J Immunol 156:1668-75
Arnett, F C; Reichlin, M (1995) Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P. Am J Med 99:465-72
James, J A; Gross, T; Scofield, R H et al. (1995) Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 181:453-61
Zhang, W; Reichlin, M (1995) IgM anti-A and D SnRNP proteins and IgM anti-dsDNA are closely associated in SLE sera. Clin Immunol Immunopathol 74:70-6
Reichlin, M (1995) Cell injury mediated by autoantibodies to intracellular antigens. Clin Immunol Immunopathol 76:215-9
James, J A; Harley, J B (1995) Peptide autoantigenicity of the small nuclear ribonucleoprotein C. Clin Exp Rheumatol 13:299-305
Frank, M B; Mattei, M G (1994) Mapping of the human 60,000 M(r) Ro/SSA locus: the genes for three Ro/SSA autoantigens are located on separate chromosomes. Immunogenetics 39:428-31

Showing the most recent 10 out of 60 publications